Logo

Investor FAQ

Investor FAQs Information RequestContacts
Where is CRISPR Therapeutics corporate headquarters?
 Our corporate headquarters are located at CRISPR Therapeutics, Aeschenvorstadt 36, CH-4051 Basel, Switzerland and our U.S. headquarters are located at CRISPR Therapeutics, 200 Sidney Street, Cambridge, MA 02139.
When was CRISPR Therapeutics founded?
 The Company was founded in 2013.
Where is the Company incorporated?
 CRISPR Therapeutics was incorporated as a Swiss stock corporation (Aktiengesellschaft) on October 31, 2013 under the name Inception Genomics AG and changed their name to CRISPR Therapeutics AG on April 28, 2014. The principal executive offices are located at Aeschenvorstadt 36, 4051 Basel, Switzerland.
When did CRISPR Therapeutics go public? What was the price?
 CRISPR Therapeutics announced the pricing of its IPO on October 18th, 2016 at a price of $14.00 and expects to complete the offering on or about October 24th, 2016.
What is CRISPR Therapeutics fiscal year?
 The Company’s fiscal year ends December 31st.
How is CRISPR Therapeutics stock traded?
 Our common stock is listed on the NASDAQ Market under the symbol “CRSP”.
Who is CRISPR Therapeutics transfer agent?
 The transfer agent and registrar for the common stock of CRISPR Therapeutics stock is American Stock Transfer and Trust Company LLC.
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Whom do I contact with questions about my stock?
 For questions about your stock please contact our transfer agent, American Stock Transfer and Trust Company LLC.
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
 To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, American Stock Transfer and Trust Company LLC.
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449

To replace a lost stock certificate, contact our transfer agent, American Stock Transfer and Trust Company LLC. The transfer agent can look up your records and make any necessary adjustments.
Does company have a direct stock purchase plan?
 CRISPR Therapeutics does not have a direct stock purchase plan.
Who is Company's auditor?
 The auditor for CRISPR Therapeutics is Ernst & Young, LLP.
Who is the Company’s legal counsel?
 Legal counsel for CRISPR Therapeutics is Goodwin Proctor, LLP located in Boston, Massachusetts.
Where can I find out more about CRISPR Therapeutics?
 To find out more about CRISPR Therapeutics visit our webpage at www.crisprtx.com.
Where can I get the latest corporate news releases and financial reports?
 CRISPR Therapeutics press release archive can be viewed under the “Press Releases” section under the “Investors & Media” tab and financial reports are available under the “Financial Information” section under the “Investors & Media” tab located at our website www.crisprtx.com.
How can I view documents CRISPR Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
 CRISPR Therapeutics SEC Filings can be found on www.sec.gov and are also available under the “Financial Information” section under the “Investors & Media” tab located at our website www.crisprtx.com.
Who makes up the CRISPR Therapeutics Executive Management team and Board of Directors?
 For a list of the Executive Management team and the Board of Directors please visit the “About Us” tab of our website.
Whom should I contact regarding investor inquiries?
 For investor inquiries please contact:
Christopher F. Brinzey
Westwicke Partners
EMAIL: chris.brinzey@westwicke.com
PHONE: 339-970-2843
Where are the PFIC Annual Information Statements posted?
 

Please view the 2016 PFIC Annual Information Statement here: Download Documentation 2016 PFIC Annual Statement (121 KB)